Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro

Although HAART effectively suppresses HIV-1 replication, its compromised effectiveness against non-B subtypes, the challenge of eliminating latent proviruses, life-long treatment, and viral resistance complicates the cure for HIV-1. CRISPR/Cas9, the latest genome editing tool, can overcome the limit...

Full description

Bibliographic Details
Main Author: Ravichantar, Nithya
Format: Thesis
Language:English
Published: 2020
Subjects:
Online Access:http://eprints.usm.my/52124/1/Pages%20from%20Combinatorial%20CrisprCas9%20ForSuppression%20Of%20Latent%20Hiv-1%20Provirus%20In%20Vitro.pdf
_version_ 1825906623187517440
author Ravichantar, Nithya
author_facet Ravichantar, Nithya
author_sort Ravichantar, Nithya
collection USM
description Although HAART effectively suppresses HIV-1 replication, its compromised effectiveness against non-B subtypes, the challenge of eliminating latent proviruses, life-long treatment, and viral resistance complicates the cure for HIV-1. CRISPR/Cas9, the latest genome editing tool, can overcome the limitations seen with HAART. By targeting the promoter of HIV-1 (LTR), CRISPR/Cas9 can disrupt the latent reservoirs. Here, we designed an improved CRISPR/Cas9 system, combinatorial CRISPR/Cas9 to concurrently knockdown multiple HIV-1 genes: structural (Pol and Gag), regulatory (Rev and Tat) and accessory genes (Vif). We investigated the efficacy of this tool as a therapy against different viral subtypes in a subset population . Our preliminary data, showed a huge decrease in viral load and we verified the safety of CRISPR/Cas9 in human cell lines.
first_indexed 2024-03-06T15:52:19Z
format Thesis
id usm.eprints-52124
institution Universiti Sains Malaysia
language English
last_indexed 2024-03-06T15:52:19Z
publishDate 2020
record_format dspace
spelling usm.eprints-521242022-03-31T07:08:35Z http://eprints.usm.my/52124/ Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro Ravichantar, Nithya R5-920 Medicine (General) Although HAART effectively suppresses HIV-1 replication, its compromised effectiveness against non-B subtypes, the challenge of eliminating latent proviruses, life-long treatment, and viral resistance complicates the cure for HIV-1. CRISPR/Cas9, the latest genome editing tool, can overcome the limitations seen with HAART. By targeting the promoter of HIV-1 (LTR), CRISPR/Cas9 can disrupt the latent reservoirs. Here, we designed an improved CRISPR/Cas9 system, combinatorial CRISPR/Cas9 to concurrently knockdown multiple HIV-1 genes: structural (Pol and Gag), regulatory (Rev and Tat) and accessory genes (Vif). We investigated the efficacy of this tool as a therapy against different viral subtypes in a subset population . Our preliminary data, showed a huge decrease in viral load and we verified the safety of CRISPR/Cas9 in human cell lines. 2020-11 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/52124/1/Pages%20from%20Combinatorial%20CrisprCas9%20ForSuppression%20Of%20Latent%20Hiv-1%20Provirus%20In%20Vitro.pdf Ravichantar, Nithya (2020) Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro. PhD thesis, Universiti Sains Malaysia.
spellingShingle R5-920 Medicine (General)
Ravichantar, Nithya
Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro
title Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro
title_full Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro
title_fullStr Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro
title_full_unstemmed Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro
title_short Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro
title_sort combinatorial crispr cas9 for suppression of latent hiv 1 provirus in vitro
topic R5-920 Medicine (General)
url http://eprints.usm.my/52124/1/Pages%20from%20Combinatorial%20CrisprCas9%20ForSuppression%20Of%20Latent%20Hiv-1%20Provirus%20In%20Vitro.pdf
work_keys_str_mv AT ravichantarnithya combinatorialcrisprcas9forsuppressionoflatenthiv1provirusinvitro